Genetic factors play a role in as much as 10% of all cases of breast and ovarian cancer. And yet, according to a new study published in the Journal of the American Medical Association, there is a significant number of patients who are not aware that they carry genetic risk factors for these diseases. Joseph Grzymski, the Chief Genomics Officer for Renown Health--which helped spearhead the study--spoke to ForbesWomen editor Maggie McGrath about these research findings and what they mean for doctors and patients across the U.S.

0:00 Statistics On Breast Cancer
0:40 What Genetic Screening Found In The US Population
4:01 Recommendations For Individuals And Institutors
5:58 Is Cost A Barrier To Breast Cancer Screenings
8:43 How JAMA Is Helping
13:03 What's Next?

Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1

Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:

https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript

Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.